Current clinical trials in renal cell carcinoma

Mitchell H. Sokoloff; Siamak Daneshmand; Christopher W. Ryan

doi:10.1016/j.urolonc.2005.05.007

Current clinical trials in renal cell carcinoma

Mitchell H. Sokoloff, Siamak Daneshmand, Christopher W. Ryan

Knight Cancer Institute

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

The treatment of renal cell carcinoma remains primarily surgical. Consequently, it is not surprising that urologists have been active in the design and operation of clinical trials for patients with kidney cancer. Currently, clinical trial efforts of the urologic community are focused on the adjuvant setting in patients undergoing nephrectomy at high risk for recurrence or metastasis. As newer agents become available and are applied earlier during the course of the disease, the involvement of urologists in clinical trials in renal cell carcinoma will increase. This review highlights several key trials currently available for patients with kidney cancer.

Original language	English (US)
Pages (from-to)	289-292
Number of pages	4
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	23
Issue number	4
DOIs	https://doi.org/10.1016/j.urolonc.2005.05.007
State	Published - Jul 2005

Keywords

Clinical trials
Kidney cancer
Nephrectomy
Targeted therapy

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/j.urolonc.2005.05.007

Cite this

@article{6e38bfe4fdb245ccabcf60120bbc702e,

title = "Current clinical trials in renal cell carcinoma",

abstract = "The treatment of renal cell carcinoma remains primarily surgical. Consequently, it is not surprising that urologists have been active in the design and operation of clinical trials for patients with kidney cancer. Currently, clinical trial efforts of the urologic community are focused on the adjuvant setting in patients undergoing nephrectomy at high risk for recurrence or metastasis. As newer agents become available and are applied earlier during the course of the disease, the involvement of urologists in clinical trials in renal cell carcinoma will increase. This review highlights several key trials currently available for patients with kidney cancer.",

keywords = "Clinical trials, Kidney cancer, Nephrectomy, Targeted therapy",

author = "Sokoloff, {Mitchell H.} and Siamak Daneshmand and Ryan, {Christopher W.}",

year = "2005",

month = jul,

doi = "10.1016/j.urolonc.2005.05.007",

language = "English (US)",

volume = "23",

pages = "289--292",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Current clinical trials in renal cell carcinoma

AU - Sokoloff, Mitchell H.

AU - Daneshmand, Siamak

AU - Ryan, Christopher W.

PY - 2005/7

Y1 - 2005/7

N2 - The treatment of renal cell carcinoma remains primarily surgical. Consequently, it is not surprising that urologists have been active in the design and operation of clinical trials for patients with kidney cancer. Currently, clinical trial efforts of the urologic community are focused on the adjuvant setting in patients undergoing nephrectomy at high risk for recurrence or metastasis. As newer agents become available and are applied earlier during the course of the disease, the involvement of urologists in clinical trials in renal cell carcinoma will increase. This review highlights several key trials currently available for patients with kidney cancer.

AB - The treatment of renal cell carcinoma remains primarily surgical. Consequently, it is not surprising that urologists have been active in the design and operation of clinical trials for patients with kidney cancer. Currently, clinical trial efforts of the urologic community are focused on the adjuvant setting in patients undergoing nephrectomy at high risk for recurrence or metastasis. As newer agents become available and are applied earlier during the course of the disease, the involvement of urologists in clinical trials in renal cell carcinoma will increase. This review highlights several key trials currently available for patients with kidney cancer.

KW - Clinical trials

KW - Kidney cancer

KW - Nephrectomy

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=21844436790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21844436790&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2005.05.007

DO - 10.1016/j.urolonc.2005.05.007

M3 - Review article

C2 - 16018946

AN - SCOPUS:21844436790

SN - 1078-1439

VL - 23

SP - 289

EP - 292

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 4

ER -

Current clinical trials in renal cell carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this